FDMT - Ocugen among top healthcare gainers this week; Alzheimer's setback hurts Cortexyme

Ocugen (NASDAQ:OCGN) made it into the list of best healthcare performers this week as its development plans for the COVID-19 shot made progress in the U.S., while Cortexyme (NASDAQ:CRTX) lost more than a quarter of value after a disappointing outcome for an Alzheimer’s trial. The healthcare stocks in the S&P 500 recorded the third consecutive weekly gain with a rise of ~1.6% outperforming the ~1.3% gain in the S&P 500 Index. Led by health tech stocks, the sector became the fourth-best performer in the index. Among stocks with more than $300M market capitalization and over 100K average daily volume over the past five sessions, Inotiv (NASDAQ:NOTV) dominated with a ~43.5% rise ahead of a special shareholder meeting scheduled by the company for next week. At the meeting On Nov. 04, Inotiv (NOTV) will ask its investors to vote on, among other things, a proposal to issue common stock in connection with a merger agreement between the company

For further details see:

Ocugen among top healthcare gainers this week; Alzheimer’s setback hurts Cortexyme